Patent details
EP1819326 Title: DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
Basic Information
- Publication number:
- EP1819326
- PCT Application Number:
- PCT/US/2005/043044
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP058262197
- PCT Publication Number:
- WO/2006/058316
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
- French Title of Invention:
- POSOLOGIE D'UN AGONISTE DU RECEPTEUR S1P
- German Title of Invention:
- DOSIERUNGSPLAN EINES S1P-REZEPTORAGONISTEN
- SPC Number:
Dates
- Filing date:
- 28/11/2005
- Grant date:
- 02/07/2014
- EP Publication Date:
- 02/07/2014
- PCT Publication Date:
- 01/06/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/08/2007
- EP B1 Publication Date:
- 02/07/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 28/11/2025
- Renunciation date:
- Revocation date:
- 28/11/2014
- Annulment date:
Owner
- From:
- 28/11/2005
- Name:
- Novartis AG
- Address:
- Corporate Intellectual Property Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- KOVARIK John, M.
- Address:
- Switzerland (CH)
2
- Name:
- APPEL-DINGEMANSE Silke
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 631483 P
- Priority Date:
- 29/11/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/135;
| Filing date | Document type | Number of pages |
|---|